Atrial Fibrillation in Older Patients with Syncope and Dementia: Insights from the Syncope and Dementia Registry.


Journal

Journal of the American Medical Directors Association
ISSN: 1538-9375
Titre abrégé: J Am Med Dir Assoc
Pays: United States
ID NLM: 100893243

Informations de publication

Date de publication:
09 2020
Historique:
received: 18 09 2019
revised: 22 01 2020
accepted: 26 01 2020
pubmed: 18 3 2020
medline: 24 6 2021
entrez: 18 3 2020
Statut: ppublish

Résumé

To evaluate the clinical characteristics and the long-term outcome of atrial fibrillation (AF) patients with dementia and history of syncope or falls. Observational: analysis of a prospective registry. Between 2012 and 2016, the Syncope and Dementia Registry enrolled patients in 12 geriatric departments. Follow-up evaluation was at 12 months. Clinical, functional, and cognitive assessment. Of the 522 patients (women, 62.1%; Mini-Mental State Examination 17 ± 6), 26.4% have or presented an AF history. Patients with AF were older (85 ± 6 vs 83 ± 6 years, P = .012), with higher heart rate (78 ± 17 vs. 73 ± 14 bpm, P < .001), prescribed drugs (6.9 ± 2.9 vs 5.9 ± 2.7, P < .001), and an increased number (3.9 ± 2.0 vs 3.0 ± 1.8, P < .001) and severity of comorbidities. Oral anticoagulant therapy was underprescribed (39.9%). Cardiac syncope was more frequently diagnosed (18.8 vs 4.9%, P < .001). At multivariate analysis, AF patients were characterized by advanced age, a higher severity of comorbidities, a greater number of prescribed drugs, an increased heart rate, and a more frequent presence of cardiac symptoms. One-year mortality differed little between patients with and without AF (27.7 vs 22.1%, P = .229). In the arrhythmia group, multivariate predictors of prognosis were disability (number of lost BADLs; P = .020) and a higher heart rate (P = .006). AF and postural stability-related issues often co-exist in persons with dementia. This complex of conditions is associated with an intricate clinical picture, underprescription of oral anticoagulants, and high long-term mortality. Future studies are needed to evaluate the effects of therapy optimization in this population.

Identifiants

pubmed: 32179002
pii: S1525-8610(20)30148-1
doi: 10.1016/j.jamda.2020.01.110
pii:
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1238-1242

Informations de copyright

Copyright © 2020 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Alice Ceccofiglio (A)

Department of Medicine and Geriatrics, Careggi Hospital and University of Florence, Florence, Italy.

Stefano Fumagalli (S)

Department of Medicine and Geriatrics, Careggi Hospital and University of Florence, Florence, Italy. Electronic address: stefano.fumagalli@unifi.it.

Chiara Mussi (C)

Centro di Valutazione e Ricerca Gerontologica, Chair of Geriatrics, University of Modena and Reggio Emilia, Modena, Italy.

Enrico Mossello (E)

Department of Medicine and Geriatrics, Careggi Hospital and University of Florence, Florence, Italy.

Mario Bo (M)

SCDU Geriatria e Malattie Metaboliche dell'Osso, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.

Anna Maria Martone (AM)

Department of Geriatrics, Neurosciences and Orthopedics, Catholic University of the Sacred Heart, Rome, Italy.

Giuseppe Bellelli (G)

Department of Health Sciences, University of Milano Bicocca and Acute Geriatric Unit, San Gerardo Hospital, Monza, Italy.

Franco Nicosia (F)

Medicine and Geriatric Unit, Spedali Civili of Brescia, Brescia, Italy.

Daniela Riccio (D)

Geriatric Department, SS. Trinità Hospital, Cagliari, Italy.

Assunta Langellotto (A)

S. Maria di Ca' Foncello Hospital, Treviso, Italy.

Gianni Tava (G)

Geriatric Unit, Santa Chiara Hospital, Trento, Italy.

Virginia Boccardi (V)

Institute of Gerontology and Geriatrics, Department of Medicine, University of Perugia, S. Maria della Misericordia Hospital, Perugia, Italy.

Elisabetta Tonon (E)

S. Jacopo Hospital, Azienda USL 3, Pistoia, Italy.

Pasquale Abete (P)

Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.

Andrea Ungar (A)

Department of Medicine and Geriatrics, Careggi Hospital and University of Florence, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH